These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27030117)

  • 1. [Anti-diabetic therapy and cardiovascular disease].
    Mannucci E
    G Ital Cardiol (Rome); 2016 Mar; 17(3 Suppl 2):3s-4. PubMed ID: 27030117
    [No Abstract]   [Full Text] [Related]  

  • 2. Diabetes management: More than just cardiovascular risk?
    Zimmerman RS; Pantalone KM
    Cleve Clin J Med; 2014 Nov; 81(11):672-6. PubMed ID: 25368217
    [No Abstract]   [Full Text] [Related]  

  • 3. [112th Scientific Meeting of the Japanese Society of Internal Medicine: Symposium: Emerging Comorbidities of Diabetes Mellitus: Drug Therapy of Diabetes Mellitus to Prevent Complications].
    Inagaki N
    Nihon Naika Gakkai Zasshi; 2015 Sep; 104(9):1912-6. PubMed ID: 30160897
    [No Abstract]   [Full Text] [Related]  

  • 4. Glycemic control and cardiovascular mortality.
    Riddle MC
    Curr Opin Endocrinol Diabetes Obes; 2011 Apr; 18(2):104-9. PubMed ID: 21522000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the development of new PPAR agonists in diabetes.
    Cavender MA; Nicholls SJ; Lincoff AM
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S32-7. PubMed ID: 20489419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-diabetic therapy and cardiovascular risk].
    Mannucci E
    G Ital Cardiol (Rome); 2014 Dec; 15(12 Suppl 2):3S. PubMed ID: 25623544
    [No Abstract]   [Full Text] [Related]  

  • 7. Top 10 facts you should know about diabetes.
    Call RJ; Wofford MR; Riche DM
    J Miss State Med Assoc; 2012 Aug; 53(8):275-7. PubMed ID: 23094391
    [No Abstract]   [Full Text] [Related]  

  • 8. Draft FDA guidance for assessing the safety of glucose lowering therapies: a missed opportunity?
    Khunti K; Davies MJ; Marx N; Buse JB
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):810-811. PubMed ID: 32946819
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiologists and the management of blood sugar: a Chinese perspective.
    Hu DY; Guo YF
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):509. PubMed ID: 18719711
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
    Saha SA; Tuttle KR
    Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type 2 diabetic as cardiovascular risk patient].
    Krankenpfl J; 2005; 43(4-6):106. PubMed ID: 16171052
    [No Abstract]   [Full Text] [Related]  

  • 12. How important is diabetes as a risk factor for cardiovascular and other diseases in older adults?
    Kengne AP; Patel A
    PLoS Med; 2006 Oct; 3(10):e424. PubMed ID: 17048981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Early insulin therapy reduces cardiovascular risk].
    Med Monatsschr Pharm; 2007 Apr; 30(4):160-1. PubMed ID: 17484451
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipeptidyl peptidase-4 inhibitors in cardioprotection: a promising therapeutic approach.
    Dai Y; Dai D; Mercanti F; Ding Z; Wang X; Mehta JL
    Acta Diabetol; 2013 Dec; 50(6):827-35. PubMed ID: 23824323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of diabetes and cardiovascular disease among prediabetic individuals: lifestyle versus drug interventions.
    Hu FB
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):810-2. PubMed ID: 22195302
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of diabetic complications: how can we learn by seeking and blundering?
    Pafili K; Papanas N; Maltezos E
    Angiology; 2015 Apr; 66(4):301-3. PubMed ID: 25092682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mortality from cardiovascular diseases in diabetics as a function of methods of hypoglycemic treatment].
    Królewski AS; Czyzyk A; Janeczko D; Kopczyński J
    Pol Arch Med Wewn; 1978 Mar; 59(3):285-93. PubMed ID: 673877
    [No Abstract]   [Full Text] [Related]  

  • 18. [The cardiovascular outcome is critical].
    Stiefelhagen P
    MMW Fortschr Med; 2016 Feb; 158(3):68. PubMed ID: 27119710
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of thiazolidinedione use and cardiovascular risk: is it all about the sugar?
    Krantz MJ
    Pharmacotherapy; 2006 Jul; 26(7):1049; discussion 1049-50. PubMed ID: 16803430
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of oral agents in improving cardiovascular prognosis in diabetes mellitus.
    Hirsch RL
    Mayo Clin Proc; 2010 Jan; 85(1):99; author reply 99-101. PubMed ID: 20042566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.